FDA recalls eye drops over possible 'foreign substance'
The FDA has issued a nationwide recall for 2.5 million bottles of prescription eye drops due to concerns regarding a foreign substance and sterility.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
The FDA issued a nationwide recall for 2.5 million bottles of prescribed steroid eye drops due to concerns regarding sterility and the presence of foreign material. The story quieted without a definitive conclusion in the coverage.
Epilogue added 107d ago, after coverage quieted.
The brief
The Food and Drug Administration is recalling millions of bottles of prescription steroid eye drops. This action follows concerns identified by the agency regarding the presence of foreign material and potential sterility issues within the products.
Coverage from outlets including The New York Times, WCYB, and Ophthalmology Times Europe highlights that the recall is nationwide in scope. Reports confirm that 2.5 million bottles are affected by these safety concerns.
Future updates will clarify which specific products are included in the recall. Coverage does not yet specify the origin of the foreign material or the timeline for the retrieval of the affected bottles from distribution channels.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 107d ago.
Quick answers
What is the reason for the eye drop recall?
The FDA issued the recall due to concerns about sterility and the presence of a foreign substance.
How many bottles are affected?
Multiple sources report that approximately 2.5 million bottles are subject to the recall.
Are these over-the-counter or prescription drops?
Coverage identifies the affected items as prescription steroid eye drops.
Coverage (11)
- FDA Recalls 2.5M Bottles of Eyedrops Over 'Foreign Material' Newser · 110d ago
- Prescription eye drops recalled nationwide by FDA Ophthalmology Times Europe · 110d ago
- 2.5 million bottles of eye drops recalled nationwide, FDA warns WXII · 111d ago
- Millions of Eye Drop Bottles Recalled Over Contamination Concerns The New York Times · 111d ago
- Millions of Eye Drop Bottles Recalled Nationwide Yahoo · 111d ago
- Nationwide Alert: 2.5 Million Bottles of Eye Drops Recalled AOL.com · 111d ago
- Millions of eye drops recalled nationwide. See affected products MSN · 111d ago
- FDA recalls more than 2.5 million bottles of commonly prescribed steroid eye drops WCYB · 111d ago
- Recall alert: 2.5M bottles of eye drops recalled for foreign substance WSB-TV · 111d ago
- Recall alert: 2.5M bottles of eye drops recalled for foreign substance Boston 25 News · 111d ago
- Eye drops sold nationwide recalled after FDA cites concerns over sterility Houston Chronicle · 111d ago
Topics
Related trends
Peptide peddlers cheer as RFK Jr. unilaterally grants access, overruling FDA
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
RFK Jr. plans to make 6 unapproved peptides available for temporary sale
RFK Jr. plans to bypass FDA regulations to allow the temporary sale of six unapproved peptides, sparking reactions from industry proponents.
Kennedy to Allow Broad Use of Unapproved Peptide Injections
The Trump administration, led by RFK Jr., is easing access to unapproved peptide injections despite opposition from FDA scientists.
FDA scientists opposed the Trump administration’s effort to ease peptides access
The Trump administration is bypassing traditional FDA approvals to expand access to unapproved peptides, sparking conflict with agency scientists.
Dementia cases in US projected to rise dramatically by 2050, study finds
A new global study projects that dementia cases worldwide could climb significantly in the coming decades.
FDA offers new details on quicker approval pathway for personalized gene therapies
12 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.